PMSF Translational Research Award

Overview

_NOTE: Early submissions of letters of intent prior to March 1st are highly encouraged._

We are seeking grant applications which bridge the gap between promising pilot laboratory data and the development of new therapeutics or new clinical assessments for Phelan-McDermid syndrome. Example areas of interest include but are not limited to: follow-up characterization studies to drug screens, cross-disorder clinical approaches, funding for remaining experiments before solidifying a pharmaceutical relationship, and adjustment of assessments or the development of new assessments which more accurately measure Phelan-McDermid syndrome phenotypes. Applications with clinical relevance will be preferred.

Eligibility

_You can learn more about this opportunity by visiting the funder's website._

* Applicant must hold a full-time position at a university/institution or an organization with 501c3 status.
* Applicants must have an MD, PhD, or MD/PhD. Applicants with a master's degree in life sciences are also eligible only if they are in a full-time professor position.
* Open to all stages of investigators post-graduate degree.
* Co-Principal Investigators (Co-PIs) who share equal responsibility on the application are allowed.
* Co-Investigators (Co-Is) who bring additional expertise but do not have primary responsibility for the application are also allowed.
* Neither Co-PIs, nor Co-Is are required. Applicants without these team members will not be at a disadvantage.
* International applicants welcome to apply.

Ineligibility

* Applicant and/or any team member of applicant cannot be involved in more than one PMSF grant application type per year.
* No portion of these funds shall be used to cover indirect institution costs.